Federal Register / Vol. 62, No. 200 / Thursday, October 16, 1997 / Notices 53791

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.866, Aging Research,

National Institutes of Health)

Dated: October 9, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–27443 Filed 10–15–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of General Medical

Sciences; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

advisory committee meeting of the

National Institute of Medical Sciences

Special Emphasis Panel

Committee Name: MBRS Subcommittee.

Date: November 13–14, 1997.

Time: 8:30 a.m.–5:00 p.m.

Place: Natcher Conference Center,

Conference Room C, 45 Cener Drive,

Bethesda, MD 20892–6200.

Contact Person: Bruce K. Wetzel, Ph.D.,

Scientific Review Administrator, NIGMS,

Office of Scientific Review, 45 Center Drive,

Room 2AS–19, Bethesda, MD 20892–6200.

Purpose: To review and evaluate program

project applications.

This meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6). Title 5 U.S.C. The

discussions of these applications could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.821, Biophysics and

Physiological Sciences; 93.859,

Pharmacological Sciences; 93.862, Genetics

Research; 93.863, Cellular and Molecular

Basis of Disease Research; 93.880, Minority

Access Research Careers [MARC]; and

93.375, Minority Biomedical Research

Support [MBRS].)

Dated: October 9, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–27444 Filed 10–15–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Arthritis and

Musculoskeletal and Skin Diseases;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Arthritis and

Musculoskeletal and Skin Diseases

Special Emphasis Panel (SEP) meeting:

Name of SEP: NIAMS SEP Osteoarthritis

Review.

Date: December 9–10, 1997.

Time: December 9–8:00 a.m.–5:00 p.m.;

December 10—8:00 a.m.–adjournment.

Place: Holiday Inn Chevy Chase, 5520

Wisconsin Avenue, Bethesda, Maryland

20815.

Contact Person: Tommy L. Broadwater,

Ph.D., Scientific Review Administrator,

Natcher Building, 45 Center Drive, Rm

5AS25U, Bethesda, Maryland 20892–6500,

Telephone: 301–594–4952.

Purpose/Agenda: To evaluate and review

research grant applications.

This meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C. The

discussion of these applications could reveal

confidential trade secrets or commercial

property such as patentable material and

personal information concerning individuals

associated with the applications, the

disclosure of which would constitute a

clearly unwarranted invasion of personal

privacy.

(Catalog of Federal Domestic Assistance

Program Nos. [93.846, Project Grants in

Arthritis, Musculoskeletal and Skin Diseases

Research], National Institutes of Health,

HHS)

Dated: October 10, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–27447 Filed 10–15–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases; Notice

of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Diabetes and

Digestive and Kidney Diseases Special

Emphasis Panel meeting:

Name of SEP: ZDK1–GRB5–J1 P.

Date: December 2–4, 1997.

Time: 7:30 PM.

Place: Empire Radisson Hotel, 44 West

63rd Street, New York, New York 10023.

Contact Person: Francisco O. Calvo, Ph.D.,

Chief Special Emphasis Panel, Review

Branch, DEA, NIDDK, Natcher Building,

Room 6as-37E, National Institutes of Health,

Bethesda, Maryland 20892–6600, Phone:

(301) 594–8897.

Purpose/Agenda: To review and evaluate

grant applications.

This meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion on personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.847–849, Diabetes, Endocrine

and Metabolic Diseases; Digestive Diseases

and Nutrition; and Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health)

Dated: October 10, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–27449 Filed 10–15–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute on Drug Abuse

(NIDA) Special Emphasis Panel

Meeting.

Purpose/Agenda: To review and evaluate

grant applications.

Name of Committee: NIDA Special

Emphasis Panel (Molecular, Cellular and

Chemical Neurobiology).

Date: October 24, 1997.

Time: 11:00 a.m.

Place: Marriott Hotel of New Orleans, 555

Cannal Street, New Orleans, LA 70130.

Contact Person: Gamil Debbas, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–2620.

The meeting will be closed in accordance

with provisions set forth in secs. 552b(c)(4)

and 552b(c)(6), Title 5, U.S.C. The

applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, disclosure of